Recently, several studies revealed that the regulation of APOBEC3B in cancer can induce T cell responses by affecting neoepitopes [23,24,25], and is associated with a greater likelihood of response to immunotherapy response in non-small cell lung cancer [26], head and neck cancer, bladder cancer [27], breast cancer [25,28], and melanomas [23]. This evidence concerns the gene APOBEC3B and cancer.